BRD4 and cancer: Our efforts have led to the discovery of a representative compound 13 (4-chloro-2-methoxy-N-(2-oxo-2H-chromen-6-yl)benzenesulfonamide), which binds to BRD4 with nanomolar affinities and shows low micromolar potencies in cell growth inhibition against four human cancer cell lines.